CVRx appoints John Landry as chief financial officer
MINNEAPOLIS - CVRx, Inc., a medical device company specializing in neuromodulation solutions for cardiovascular diseases, has appointed John Landry as their new Chief Financial Officer. Landry succeeds Jared Oasheim, who will continue with the company during a transition period. Landry is set to assume the CFO role following the company's Form 10-Q filing for the quarter ending September 30, 2026. Oasheim's tenure with CVRx began in 2015, and he played a crucial role in the company's successful IPO.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
